Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

Osmetech : The Next Generation - Info and Links thread. (OMH)     

DITCHPIG - 30 Apr 2004 15:09

omhnew4vo.gifomhlogo24kn.gifomhnew4vo.gifomhbot8kj.gif

UBS AG buy 8,825,000 6.7%

eSensor LAUNCHED!!!

FDA clearance for Cystic Fibrosis DNA Test

Sales of the eSensor instrument and CF test will commence in the first half of 2006 as planned.. .

James White, CEO of Osmetech said:

'Gaining FDA clearance for our first microarray based test developed for our new eSensorTM molecular diagnostics instrument is a major step forward for our Molecular Diagnostics Division and will help to establish Osmetech as a key player in the fast growing moleculardiagnostics market. In addition, this FDA clearance helps to validate our microarray technology for routine use in the laboratory.

Critical Care DivisionThe Division has a strong product portfolio and is well placed to continue the growth of instrument placements throughout the world, leading to revenues from proprietary consumables for a number of years to come.Sales of OPTI instruments and consumables remained strong resulting from increased sales of the new touchscreen version of the long-established OPTI (CCA). In 2006 we will start to see an important contribution to sales from the new OPTI LION portable electrolyte analyser and the OPTI R blood gas and electrolyte analyser with reusable consumable as these products are rolled out internationally.'

Molecular Diagnostics DivisionFollowing FDA approval of the eSensorTM platform Osmetech are now looking to progress discussions with strategic partners who are looking for cost effective and easy to use instrumentation and consumables to work on other complex assays both in the healthcare and non healthcare markets. The next Osmetech Molecular test targeted for FDA submission will be the CYP 450 pharmacogenomics assay, which is currently in development.

James White, CEO of Osmetech commented:

'We have been delighted with the rapid integration of the CMS business acquired in July. The powerful combination of the eSensor product together with OPTI GENE provides Osmetech Molecular Diagnostics with an excellent position in this rapidly developing and growing market sector. Both products remain on schedule for launch and revenue generation in the first half of 2006'

Sales to year end up over 40%

Osmetech has reported a strong rise in sales in the latter part of 2005 with growth driven byabove-forecast revenues at its Critical Care blood gas analysis division.. Sales for the Critical Care division in calendar year 2005 exceeded $14.7m, representing an increase of over 60% compared to the calendar year 2004. Approximately half of this overall growth is due to sales to veterinary distribution partner, IDEXX Laboratories, Inc.

Vetstat Exceeds Idexx Expectations

Sales of the VetStat electrolyte and blood gas analyser have been very encouraging and continue to exceed expectations. IDEXX's sales successes and continuing marketing efforts should result in further strong growth for the foreseeable future. As the installed base of instruments becomes established, revenues from proprietary consumables are expected to increase as a proportion of this veterinary business. Following a deal with leading US vetinary hopsital chain Banfield, Idexx are contracted to supply an additional 450 Vetstat devices over the coming year.Good progress is also being made with IDEXX on the development and supply contract to create a new platform for measuring critical care parameters based on Osmetech's proprietary optical fluorescence technology and consumables. It is anticipated that this market leading product is on target for launch late 2006/2007.

Critical Care Product Range - In Production

OPTI-CCA Opti CCA. Sales revenues for this product and consumables were in excess of $14,000,000 in 2005. More than 5000 units are in use worldwide.OPTI-LION Opti Lion. Newly launched in late 2005 this device competes head on with more complex systems. Significant sales are forcast for 2006/7OPTI-R Opti R. Newly launched in late 2005 the OPTI R is a compact blood gas analyzer using a combination of proven maintenance-free sensor technology, intuitive graphic user interface and automated system monitoring to increase operator convenience and reduce time spent on blood gas testing while delivering fast reliable results.OPTI-2L Opti 2 Line. Designed for portability, the Osmetech OPTI Analyzer is always ready for testing wherever you need it for measurement of pH/blood gas, total hemoglobin, oxygen saturation, electrolytes and glucose.

Critical Care Consumable Product Range - In Production

SamplerComfort Sampler. Launched in July 2004 this product, has become the arterial blood sampling method most preferred by therapists and patients. Sales are expected to generate revenues in excess of $2,000,000.Cassette Sensor Cassette. Over 4000 tests per day are made using Opti consumables generating revenues in excess of $8,000,000Callibration The calibration gas bottle assures accurate calibration prior to each sample measurement.DataTrolData Management Software. Consolidate test results in one centralized location

Molecular Diagnostics Product Range - In Production

Opti-GeneOpti-Gene. The system allows for the detection of DNA and RNA targets using PCR or RT-PCR based assays in hospital and clinical research laboratories. Lauching in May first test will be for Factor V Leiden MutationeSensoreSensor. a low cost instrument and consumable for moderately complex genetic testing where the detection of multiple gene targets is required. Initally tests will be for cystic fibrosis and CYP450.BiochipBiochip. Single use bio-chip disposable cartridge for use in the eSensor device.ConsumableConsumables. Disposable cartridge for use in the eSensor device.OPTI Tube OPTI Tube Primary consumable for the OPTI Gene and compatible with the large installed base of LightCycler instrument. Launching from May

Product Range - Licenced to Third Party

VetStat VetStat Based on the OPTI-CCA device. This instrument is being sold in to the vetinary market by industry leading corporation IDEXX. Considerable sales are being made Cassettes Cassette : The only blood gas system calibrated for veterinary-specific reference ranges. An increasing range producing substantial sales. Being sold by Idexx for the Vetstat deviceOPTI Tube OPTI Tube Licensed to Roche to manufacture and sell plastic consumable vials for use on its large installed base of LightCycler instruments. Osmetech plans to manufacture and sell the plastic consumable vials as an alternative to glass vials itself. Sales are anticipated to start early 2006 AVOX 4000 AVOX 4000 The AVOXimeter 4000 provides a fast, accurate assessment of patient oxygenation at the bedside. Sold worldwide (-usa) by Osmetech in a deal with Avox

Buisness Partners
idexxlogo.gifroche_logo.giflogo.gifsysmex_logo.jpg

Major Shareholders
Organisation Shareholding % Gartmore 24,109,657 18.29% Schroder 18,874,284 14.32 UBS AG 8,825,000 6.70TD Waterhouse 7,011,137 5.32 Barclays Nom 6,638,092 5.04 Pershing Keen 5,870,773 4.45HSBC Global Nom 6,544,718 4.97 Roche 2,444,688 1.8 Marlborough UK Micro Cap Director Holdings James White 208,092 Gordon Hall 104,966 D Sandilands 61,597 GB Kuenster 33,054 A Marek 26,190 ADVFN Posters 5,896,564 4.5 Total Holdings 86,648,812 65.7%

Mouse Over Images For Product Data
backup_counter.cgi?counter_id=644347updater.cgi?counter_id=644347&increment=If regular posters would like to be included in the ADVFN figure and if you are not bothered about the figures being public then post your long-term holding here.IE the number of shares you intend to keep for say more than 6 months?Alternatively if you'd rather keep your holdings secret but still want contribute to the overall figure then drop me a line to ditchpig@ntlworld.com

DITCHPIG - 05 Aug 2004 16:35 - 40 of 242

windys160,
6p by Friday would cause too much volatility. We should be looking for steady and sustained growth from now on. The quick spikes caused by short term traders have not done long term holders any favours over the last 12 months. I'm sure we would now be sitting at a higher price had it not been for the volatility caused by idiots like Steven Foley in the Indy telling people to go short. The MM seem to have managed this very carefully this time, they opened the spread up to effectively kill the day traders just when it looked like it was going to be lift off last Friday.
Well no fireworks at the end so guess we will have to wait and see what tomorrow brings.

windys160 - 06 Aug 2004 07:00 - 41 of 242

dicthpig always thought this was going to be med - long term thing, i have to agree with you on people being advised that this was a short term share not on your nelly, would have thought people would have guested that by now, let's hope today when the results come out we get the news we've been waiting for about sale's of the new products and the price starts on the upward trend that we have been waiting for so long now. let the good times roll. cheers windy

windys160 - 06 Aug 2004 07:49 - 42 of 242

there we have it news of a nice little contract for the at least 10 years pre tax losses reduced and a serious increase in sales all looking good to me, now lets see it reflected in the price :-))

astonvilla - 06 Aug 2004 08:06 - 43 of 242

up 10% before trading.............this will hit 5p today :-))))))

windys160 - 06 Aug 2004 08:09 - 44 of 242

plenty of buying today but keeps droping back slightly on the sell are the MM playing with us today?

ptholden - 06 Aug 2004 08:15 - 45 of 242

Unless you are in short term, it doesn't realy matter what the MMs are up to. This is all very good news for the long haul. IMHO

seawallwalker - 06 Aug 2004 08:16 - 46 of 242

Of course.

Monkey shake the tree, all the coconouts fall out.

Hold tight!

seawallwalker - 06 Aug 2004 08:17 - 47 of 242

Big Al says:-

OMH - agreement opens verterinarian market to technology. "The impact upon the next financial year should be significant".
Might fly!!
http://moneyam.uk-wire.com/cgi-bin/articles/200408060700086991B.html
Results - http://moneyam.uk-wire.com/cgi-bin/articles/200408060700086992B.html

teletigger - 06 Aug 2004 08:27 - 48 of 242

Ha......who's gonna blink first. Time to enter m'thinks.
regards

seawallwalker - 06 Aug 2004 08:42 - 49 of 242

Massive buys already 5M and rising.

Not at all surprised here with the news and results.

windys160 - 06 Aug 2004 08:53 - 50 of 242

could we reach 10m buys today :-))

ptholden - 06 Aug 2004 10:11 - 51 of 242

The vet tie-up came as a bit of a surprise, another market to tap in to and quite a big one by the looks of it, 10 million looks easy today, I wonder how long the price will be kept down? As long as it stays this low, it surely must be regarded as a buying opportunity?

Good luck to all

Regards

PTH

windys160 - 06 Aug 2004 14:47 - 52 of 242

still keeping the price down, surprised by this after .45p gain just before the start of trading, buying seems to have slowed down as day goes on, results and positive news all good but price is not reflecting this as yet hope to see it rise soon :-))

mickeyskint - 06 Aug 2004 16:01 - 53 of 242

What time frame are we looking at on this one +12 months or longer.

DITCHPIG - 06 Aug 2004 16:48 - 54 of 242

Christ. What does this company have to do to get a positive reaction from the share price? Some truely fantastic news buys 3 million more than the number of sells and we end up down. EVO have killed any rise today by sitting on the offer all day. I wonder what their game is.
I'll update the header with the new info over the weekend.

windys160 - 10 Aug 2004 06:41 - 55 of 242

still going down shocked to see such a down turn in the price was expecting it to rise this week anyone with views to why the price is still going down, with the company giving us the best news we have had for a long time and getting closer to making a profit next year this is only good for the price surely :-((

panic - 17 Aug 2004 10:21 - 56 of 242

Morning All, Does Anyone Know the date of the final results yet, (due Q3 2004 )

astonvilla - 17 Aug 2004 11:29 - 57 of 242

some people amaze me.....LoL

windys160 - 17 Aug 2004 17:27 - 58 of 242

why are they keeping the price down what are they affraid of, this comapny is doing well with plenty in the pipe line but still they fall ;-( is there any ryhme or reason for this surley they should be 6p by now...

teletigger - 17 Aug 2004 18:24 - 59 of 242

Hmmm....Maybe the MM's are too surley. Miserable bastardo's :-)
regards
Register now or login to post to this thread.